Özkocaman, V. Et Al. 2022. Efficacy of plerixafor plus granulocyte colony-stimulating factor (G-CSF) in patients with multiple myeloma and lymphoma who have had mobilization failure with at least two regimens. A retrospective single-center study. 48th Annual Meeting EBMT , (Praha, Czech Republic), 75.

Özkocaman, V., Özkalemkaş, F., Pınar, İ. E., Ersal, T., Buldu, M., & Gürsoy, V., (2022). Efficacy of plerixafor plus granulocyte colony-stimulating factor (G-CSF) in patients with multiple myeloma and lymphoma who have had mobilization failure with at least two regimens. A retrospective single-center study . 48th Annual Meeting EBMT (pp.75). Praha, Czech Republic

Özkocaman, VİLDAN Et Al. "Efficacy of plerixafor plus granulocyte colony-stimulating factor (G-CSF) in patients with multiple myeloma and lymphoma who have had mobilization failure with at least two regimens. A retrospective single-center study," 48th Annual Meeting EBMT , Praha, Czech Republic, 2022

Özkocaman, VİLDAN Et Al. "Efficacy of plerixafor plus granulocyte colony-stimulating factor (G-CSF) in patients with multiple myeloma and lymphoma who have had mobilization failure with at least two regimens. A retrospective single-center study." 48th Annual Meeting EBMT , Praha, Czech Republic, pp.75, 2022

Özkocaman, V. Et Al. (2022) . "Efficacy of plerixafor plus granulocyte colony-stimulating factor (G-CSF) in patients with multiple myeloma and lymphoma who have had mobilization failure with at least two regimens. A retrospective single-center study." 48th Annual Meeting EBMT , Praha, Czech Republic, p.75.

@conferencepaper{conferencepaper, author={VİLDAN ÖZKOCAMAN Et Al. }, title={Efficacy of plerixafor plus granulocyte colony-stimulating factor (G-CSF) in patients with multiple myeloma and lymphoma who have had mobilization failure with at least two regimens. A retrospective single-center study}, congress name={48th Annual Meeting EBMT }, city={Praha}, country={Czech Republic}, year={2022}, pages={75} }